Abstract
Summary
LPI (LP Information)' newest research report, the “Telmisartan API Industry Forecast” looks at past sales and reviews total world Telmisartan API sales in 2022, providing a comprehensive analysis by region and market sector of projected Telmisartan API sales for 2023 through 2029. With Telmisartan API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Telmisartan API industry.
This Insight Report provides a comprehensive analysis of the global Telmisartan API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Telmisartan API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Telmisartan API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Telmisartan API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Telmisartan API.
The global Telmisartan API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Telmisartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Telmisartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Telmisartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Telmisartan API players cover Jiangsu Zhongbang Pharmaceutical, Jiangxi Synergy Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhuhai Rundu Pharmaceutical, Gonane Pharma, Dr. Reddy's Laboratories, Octavius Pharma Pvt. Ltd and Kekule Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Telmisartan API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.98
0.99
Others
Segmentation by application
Tablets
Capsules
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Jiangsu Zhongbang Pharmaceutical
Jiangxi Synergy Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Zhuhai Rundu Pharmaceutical
Gonane Pharma
Dr. Reddy's Laboratories
Octavius Pharma Pvt. Ltd
Kekule Pharma
Zeon Health Industries
Teva API
AGC Chemicals Europe
Actavis Inc.
Tokuyama Corporation
Hoventa Pharma
Saintsun Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Telmisartan API market?
What factors are driving Telmisartan API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Telmisartan API market opportunities vary by end market size?
How does Telmisartan API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Telmisartan API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Telmisartan API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Telmisartan API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Telmisartan API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Telmisartan API.
The global Telmisartan API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Telmisartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Telmisartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Telmisartan API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Telmisartan API players cover Jiangsu Zhongbang Pharmaceutical, Jiangxi Synergy Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhuhai Rundu Pharmaceutical, Gonane Pharma, Dr. Reddy's Laboratories, Octavius Pharma Pvt. Ltd and Kekule Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Telmisartan API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.98
0.99
Others
Segmentation by application
Tablets
Capsules
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Jiangsu Zhongbang Pharmaceutical
Jiangxi Synergy Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Zhuhai Rundu Pharmaceutical
Gonane Pharma
Dr. Reddy's Laboratories
Octavius Pharma Pvt. Ltd
Kekule Pharma
Zeon Health Industries
Teva API
AGC Chemicals Europe
Actavis Inc.
Tokuyama Corporation
Hoventa Pharma
Saintsun Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Telmisartan API market?
What factors are driving Telmisartan API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Telmisartan API market opportunities vary by end market size?
How does Telmisartan API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Telmisartan API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Telmisartan API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Telmisartan API by Country/Region, 2018, 2022 & 2029
2.2 Telmisartan API Segment by Type
2.2.1 0.98
2.2.2 0.99
2.2.3 Others
2.3 Telmisartan API Sales by Type
2.3.1 Global Telmisartan API Sales Market Share by Type (2018-2023)
2.3.2 Global Telmisartan API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Telmisartan API Sale Price by Type (2018-2023)
2.4 Telmisartan API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Others
2.5 Telmisartan API Sales by Application
2.5.1 Global Telmisartan API Sale Market Share by Application (2018-2023)
2.5.2 Global Telmisartan API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Telmisartan API Sale Price by Application (2018-2023)
3 Global Telmisartan API by Company
3.1 Global Telmisartan API Breakdown Data by Company
3.1.1 Global Telmisartan API Annual Sales by Company (2018-2023)
3.1.2 Global Telmisartan API Sales Market Share by Company (2018-2023)
3.2 Global Telmisartan API Annual Revenue by Company (2018-2023)
3.2.1 Global Telmisartan API Revenue by Company (2018-2023)
3.2.2 Global Telmisartan API Revenue Market Share by Company (2018-2023)
3.3 Global Telmisartan API Sale Price by Company
3.4 Key Manufacturers Telmisartan API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Telmisartan API Product Location Distribution
3.4.2 Players Telmisartan API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Telmisartan API by Geographic Region
4.1 World Historic Telmisartan API Market Size by Geographic Region (2018-2023)
4.1.1 Global Telmisartan API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Telmisartan API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Telmisartan API Market Size by Country/Region (2018-2023)
4.2.1 Global Telmisartan API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Telmisartan API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Telmisartan API Sales Growth
4.4 APAC Telmisartan API Sales Growth
4.5 Europe Telmisartan API Sales Growth
4.6 Middle East & Africa Telmisartan API Sales Growth
5 Americas
5.1 Americas Telmisartan API Sales by Country
5.1.1 Americas Telmisartan API Sales by Country (2018-2023)
5.1.2 Americas Telmisartan API Revenue by Country (2018-2023)
5.2 Americas Telmisartan API Sales by Type
5.3 Americas Telmisartan API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Telmisartan API Sales by Region
6.1.1 APAC Telmisartan API Sales by Region (2018-2023)
6.1.2 APAC Telmisartan API Revenue by Region (2018-2023)
6.2 APAC Telmisartan API Sales by Type
6.3 APAC Telmisartan API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Telmisartan API by Country
7.1.1 Europe Telmisartan API Sales by Country (2018-2023)
7.1.2 Europe Telmisartan API Revenue by Country (2018-2023)
7.2 Europe Telmisartan API Sales by Type
7.3 Europe Telmisartan API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Telmisartan API by Country
8.1.1 Middle East & Africa Telmisartan API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Telmisartan API Revenue by Country (2018-2023)
8.2 Middle East & Africa Telmisartan API Sales by Type
8.3 Middle East & Africa Telmisartan API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Telmisartan API
10.3 Manufacturing Process Analysis of Telmisartan API
10.4 Industry Chain Structure of Telmisartan API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Telmisartan API Distributors
11.3 Telmisartan API Customer
12 World Forecast Review for Telmisartan API by Geographic Region
12.1 Global Telmisartan API Market Size Forecast by Region
12.1.1 Global Telmisartan API Forecast by Region (2024-2029)
12.1.2 Global Telmisartan API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Telmisartan API Forecast by Type
12.7 Global Telmisartan API Forecast by Application
13 Key Players Analysis
13.1 Jiangsu Zhongbang Pharmaceutical
13.1.1 Jiangsu Zhongbang Pharmaceutical Company Information
13.1.2 Jiangsu Zhongbang Pharmaceutical Telmisartan API Product Portfolios and Specifications
13.1.3 Jiangsu Zhongbang Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Jiangsu Zhongbang Pharmaceutical Main Business Overview
13.1.5 Jiangsu Zhongbang Pharmaceutical Latest Developments
13.2 Jiangxi Synergy Pharmaceutical
13.2.1 Jiangxi Synergy Pharmaceutical Company Information
13.2.2 Jiangxi Synergy Pharmaceutical Telmisartan API Product Portfolios and Specifications
13.2.3 Jiangxi Synergy Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Jiangxi Synergy Pharmaceutical Main Business Overview
13.2.5 Jiangxi Synergy Pharmaceutical Latest Developments
13.3 Zhejiang Huahai Pharmaceutical
13.3.1 Zhejiang Huahai Pharmaceutical Company Information
13.3.2 Zhejiang Huahai Pharmaceutical Telmisartan API Product Portfolios and Specifications
13.3.3 Zhejiang Huahai Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.3.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.4 Zhejiang Tianyu Pharmaceutical
13.4.1 Zhejiang Tianyu Pharmaceutical Company Information
13.4.2 Zhejiang Tianyu Pharmaceutical Telmisartan API Product Portfolios and Specifications
13.4.3 Zhejiang Tianyu Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zhejiang Tianyu Pharmaceutical Main Business Overview
13.4.5 Zhejiang Tianyu Pharmaceutical Latest Developments
13.5 Zhuhai Rundu Pharmaceutical
13.5.1 Zhuhai Rundu Pharmaceutical Company Information
13.5.2 Zhuhai Rundu Pharmaceutical Telmisartan API Product Portfolios and Specifications
13.5.3 Zhuhai Rundu Pharmaceutical Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhuhai Rundu Pharmaceutical Main Business Overview
13.5.5 Zhuhai Rundu Pharmaceutical Latest Developments
13.6 Gonane Pharma
13.6.1 Gonane Pharma Company Information
13.6.2 Gonane Pharma Telmisartan API Product Portfolios and Specifications
13.6.3 Gonane Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Gonane Pharma Main Business Overview
13.6.5 Gonane Pharma Latest Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Dr. Reddy's Laboratories Company Information
13.7.2 Dr. Reddy's Laboratories Telmisartan API Product Portfolios and Specifications
13.7.3 Dr. Reddy's Laboratories Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Dr. Reddy's Laboratories Main Business Overview
13.7.5 Dr. Reddy's Laboratories Latest Developments
13.8 Octavius Pharma Pvt. Ltd
13.8.1 Octavius Pharma Pvt. Ltd Company Information
13.8.2 Octavius Pharma Pvt. Ltd Telmisartan API Product Portfolios and Specifications
13.8.3 Octavius Pharma Pvt. Ltd Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Octavius Pharma Pvt. Ltd Main Business Overview
13.8.5 Octavius Pharma Pvt. Ltd Latest Developments
13.9 Kekule Pharma
13.9.1 Kekule Pharma Company Information
13.9.2 Kekule Pharma Telmisartan API Product Portfolios and Specifications
13.9.3 Kekule Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Kekule Pharma Main Business Overview
13.9.5 Kekule Pharma Latest Developments
13.10 Zeon Health Industries
13.10.1 Zeon Health Industries Company Information
13.10.2 Zeon Health Industries Telmisartan API Product Portfolios and Specifications
13.10.3 Zeon Health Industries Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zeon Health Industries Main Business Overview
13.10.5 Zeon Health Industries Latest Developments
13.11 Teva API
13.11.1 Teva API Company Information
13.11.2 Teva API Telmisartan API Product Portfolios and Specifications
13.11.3 Teva API Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Teva API Main Business Overview
13.11.5 Teva API Latest Developments
13.12 AGC Chemicals Europe
13.12.1 AGC Chemicals Europe Company Information
13.12.2 AGC Chemicals Europe Telmisartan API Product Portfolios and Specifications
13.12.3 AGC Chemicals Europe Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 AGC Chemicals Europe Main Business Overview
13.12.5 AGC Chemicals Europe Latest Developments
13.13 Actavis Inc.
13.13.1 Actavis Inc. Company Information
13.13.2 Actavis Inc. Telmisartan API Product Portfolios and Specifications
13.13.3 Actavis Inc. Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Actavis Inc. Main Business Overview
13.13.5 Actavis Inc. Latest Developments
13.14 Tokuyama Corporation
13.14.1 Tokuyama Corporation Company Information
13.14.2 Tokuyama Corporation Telmisartan API Product Portfolios and Specifications
13.14.3 Tokuyama Corporation Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Tokuyama Corporation Main Business Overview
13.14.5 Tokuyama Corporation Latest Developments
13.15 Hoventa Pharma
13.15.1 Hoventa Pharma Company Information
13.15.2 Hoventa Pharma Telmisartan API Product Portfolios and Specifications
13.15.3 Hoventa Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hoventa Pharma Main Business Overview
13.15.5 Hoventa Pharma Latest Developments
13.16 Saintsun Pharma
13.16.1 Saintsun Pharma Company Information
13.16.2 Saintsun Pharma Telmisartan API Product Portfolios and Specifications
13.16.3 Saintsun Pharma Telmisartan API Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Saintsun Pharma Main Business Overview
13.16.5 Saintsun Pharma Latest Developments
14 Research Findings and Conclusion